Finance

Lists
IMNM:NASDAQ
Immunome Inc
USD 18,00
+0,45%
(+0,080) 1D
USD 18,00
0,00% (0,00)
After hours
Closed: 21 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMNM...
Open
USD 17,99
High
USD 18,44
Low
USD 17,85
Mkt. cap
2,12 mjd
Avg. vol.
1,45 m
Volume
1,55 m
52-wk high
USD 30,06
52-wk low
USD 14,64
EPS
-USD 2,51
Beta
2,55
Shares outstanding
118,00 m
No. of employees
247
Open
USD 17,99
High
USD 18,44
Low
USD 17,85
Mkt. cap
2,12 mjd
Avg. vol.
1,45 m
Volume
1,55 m
52-wk high
USD 30,06
52-wk low
USD 14,64
EPS
-USD 2,51
Beta
2,55
Shares outstanding
118,00 m
No. of employees
247
News stories
From web sources and news partners
About Immunome Inc
CEO-
Employees247
Founded2006
HeadquartersBothell, Washington, Verenigde State van Amerika
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to IMNM in the past 3 months
Strong buy
Buy
12
Hold
1
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for IMNM in the last 3 months.
Highest
Current USD 18,00
USD 40,00 (+122,22%)
Average
USD 35,33 (+96,28%)
Lowest
USD 24,00 (+33,33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
William Blair
Buy
Initiated
USD 35,00
+94,4%
10/15/2026
Sharon Zackfia
William Blair
Buy
Initiated
USD 35,00
+94,4%
10/15/2026
Dara Azar
Stifel Nicolaus
Hold
Maintained
USD 24,00
+33,3%
10/06/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
USD 40,00
+122,2%
10/05/2026
Lukas Shumway
Barclays
Buy
Maintained
USD 36,00
+100%
10/01/2026
Matthew Venezia
Alliance Global Partners
Buy
Initiated
USD 32,00
+77,8%
09/21/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
USD 40,00
+122,2%
09/11/2026
Michael Schmidt
Guggenheim
Buy
Maintained
USD 35,00
+94,4%
08/12/2026
Unknown Analyst
Wedbush
Buy
Maintained
USD 35,00
+94,4%
08/12/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
USD 40,00
+122,2%
08/12/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
USD 36,00
+100%
08/12/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
USD 38,00
+111,1%
08/12/2026
Biren Amin
Piper Sandler
Buy
Maintained
USD 33,00
+83,3%
08/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/11/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
-
-
06/29/2026
Chad Messer
Lake Street
Buy
Maintained
USD 30,00
+66,7%
06/01/2026
Unknown Analyst
Barclays
Buy
Initiated
USD 36,00
+100%
05/28/2026
Andrew Berens
Leerink Partners
Buy
Maintained
USD 33,00
+83,3%
05/15/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
USD 35,00
+94,4%
05/13/2026
Karina Rabayeva
Truist Financial
Buy
Maintained
-
-
03/05/2026
Sudan Loganathan
Stephens
Buy
Reiterated
USD 30,00
+66,7%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
49,19 m
50,77 m
46,38 m
59,88 m
Cost of revenue
49,19 m
50,77 m
46,38 m
59,88 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,94 m
12,09 m
12,95 m
18,25 m
Operating expense
10,94 m
12,09 m
12,95 m
18,25 m
Total operating expenses
60,14 m
62,86 m
59,33 m
78,14 m
Operating income
-60,14 m
-62,86 m
-59,33 m
-78,14 m
Other non operating income
-
-
-
-
EBT including unusual items
-57,46 m
-69,90 m
-53,84 m
-73,13 m
EBT excluding unusual items
-57,46 m
-59,90 m
-53,84 m
-73,13 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-57,46 m
-69,90 m
-53,84 m
-73,13 m
Net profit margin
-
-
-
-
Earnings per share
-0,65
-0,76
-0,48
-0,65
Interest and investment income
2,68 m
2,96 m
5,49 m
5,01 m
Interest expense
-
-
-
-
Net interest expenses
2,68 m
2,96 m
5,49 m
5,01 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-59,55 m
-62,23 m
-58,73 m
-77,18 m
Gain or loss from assets sale
-50,00 k
55,00 k
79,00 k
-1,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme